市場調查報告書
商品編碼
1267461
醫療保健領域的人工智能市場——按應用(醫學成像/診斷,藥物發現,治療計劃,醫院工作流程,可穿戴設備,虛擬助手),區域和全球預測,2023-2032 年Artificial Intelligence in Healthcare Market - By Application (Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow, Wearables, Virtual Assistants), By Region & Global Forecast, 2023 - 2032 |
隨著精準醫療的普及,醫療保健領域的人工智能市場預計將在 2032 年之前穩步增長。
精準醫學比直覺醫學更受歡迎,因為它更容易獲得,簡單且便宜。 因此,人工智能技術的使用正在增加,這將推動未來的市場需求。
此外,新加坡,中國等東南亞國家融資場景有利,有望推動行業發展。 正如此前報導的那樣,中國國務院的目標是到 2030 年使中國成為世界上最大的創新中心。 為實現這一目標,中國政府在人工智能領域推出了多項舉措。 此外,新加坡政府的寶貴貢獻也將擴大市場。
基於應用,醫療保健領域的人工智能市場預計將以醫學成像和診斷為特徵。 到 2022 年,該部門的價值將超過 13 億美元,預計未來幾年將實現高速增長。
此外,市場進入者推出更多產品預計會對市場增長產生積極影響。 例如,2021 年 11 月,佳能醫療推出了一個名為 Altivity 的基於人工智能的品牌。 Altivity 有望提供高質量的圖像和應用程序並減少掃描時間。
此外,預計醫院工作流程部分在預計期間將顯著增長。 由於公眾生活方式的改變,全球慢性病和傳染病的增加也是推動市場增長的主要因素之一。
按地區劃分,由於人均醫療費用的增加和醫療系統的發展,預計亞太地區醫療保健領域的人工智能市場將顯著擴大。 同樣明顯的是,公眾的健康意識越來越強,這也有望對市場增長產生積極影響。
此外,到 2022 年,MEA 醫療保健領域的人工智能市場規模將超過 1.15 億美元,預計這一趨勢將從 2023 年持續到 2032 年。 促進人工智能在該地區醫療保健市場的應用日益廣泛的主要因素是技術創新的顯著增加和大數據的使用不斷增加。
醫療保健市場人工智能的主要參與者包括 IBM Corporation,Sophia Genetics,AiCure,Atomwise Inc.,Insilico Medicine Inc.,APIXIO Inc.,Cyrcadia Health Inc.,NVIDIA Corporation,Butterfly Network Inc,Enlitic, Inc. iCarbonX.,Modernizing Medicine,Sens.ly Inc,Virgin plus,Nanox 等。
Healthcare artificial intelligence market is set to experience steady growth through 2032 owing to the increasing adoption of precision medicine. Precision medicine is becoming more popular than intuitive medicine as it is more accessible, simple, and less expensive. This is resulting in increasing usage of AI technology, which will drive the market demand in the upcoming time.
Besides, there has been a favorable funding scenario in Southeast Asian countries like Singapore and China which are slated to drive the industry progression. As reported, the State Council of China aims to make the country the largest center of innovation in the world by 2030. To achieve that goal, the Chinese government has launched different initiatives in the field of AI. Besides, valuable contributions from the Singapore government will also expand the market.
Based on application, the healthcare artificial intelligence market is likely to be characterized by medical imaging & diagnosis. This segment was valued at more than $1.3 billion in 2022 and is projected to foresee appreciable growth in the ensuing years.
In addition, an increasing number of product launches by key participants is bound to positively affect the market growth. To cite an instance, in November 2021, an AI-based brand called Altivity was launched by Canon Medical. Altivity is expected to supply quality images and applications and can lessen the scanning time.
Besides, the hospital workflow segment is set to grow significantly during the estimated timeframe. The increasing cases of chronic and infectious diseases across the world, mainly due to the changing lifestyle of the general populace, is among the major factors, which has fostered the market growth.
In terms of region, the healthcare artificial intelligence market in the Asia Pacific is set to expand significantly owing to the increasing per capita health expenditure and development of the healthcare system. Besides, a growing awareness about human health is clearly visible among the general populace, which will also impact the market growth positively.
In addition, the MEA healthcare artificial intelligence market amassed more than $115 million in 2022, and the trend is likely to be continued over 2023-2032 as well. Some of the major factors which will contribute to the growth in the use of Artificial Intelligence in the healthcare market in the region include a substantial growth in technological innovation and an increase in the usage of big data.
Some of the key players in the healthcare artificial intelligence market include IBM Corporation, Sophia Genetics, AiCure, Atomwise Inc., Insilico Medicine Inc., APIXIO Inc., Cyrcadia Health Inc., NVIDIA Corporation, Butterfly Network Inc, Enlitic, Inc., iCarbonX., Modernizing Medicine, Sens.ly Inc, Virgin plus, Nanox, and more.